| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 16 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.23M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $624.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 49,638 | $50.08 | $2,485,988.81 | -93.8% | |
| Dec 26, 2019 | Alenson Carman65 | Principal Accounting Officer | Sell | 2,950 | $50.09 | $147,765.50 | -94.1% | |
| Nov 13, 2019 | Fouse Jacqualyn A | Chief Executive Officer | Buy | 40,322 | $31.00 | $1,249,982.00 | +2,880% | |
| Nov 13, 2019 | Schenkein David P59 | Director | Buy | 8,064 | $31.00 | $249,984.00 | +9.0% | |
| Nov 12, 2019 | Celgene Corp /de/ | 10% Owner | Buy | 403,225 | $31.00 | $12,499,975.00 | +29.3% | |
| Apr 5, 2019 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $67.71 | $203,135.49 | -5.3% | |
| Apr 1, 2019 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 10,000 | $66.57 | $665,746.72 | -22.3% | |
| Mar 15, 2019 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 10,000 | $64.16 | $641,615.00 | -38.8% | |
| Mar 5, 2019 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $67.68 | $203,032.00 | -3.5% | |
| Mar 4, 2019 | Hoerter Steven L. | Chief Commercial Officer | Sale+OE | 10,000 | $67.01 | $670,050.00 | -31.4% |